Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite Innovative Imaging Bulk Pack Design ...

Multi-center trial will assess safety and efficacy of ASI-02 contrast agent in cardiac bubble studies. ST. PAUL, Minn., April 08, 2025--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has ...

Villepinte (France), November 23, 2017 (8:00 CET) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, today announces the launch of ...

CHICAGO (CBS) -- Growing concern about common medical screenings that can catch things like cancer or heart problems. A nationwide shortage of imaging solution is putting some of those tests on hold.

NORFOLK, Va. — A global shortage has health leaders with Riverside Health System and Sentara Healthcare making another pivot. “We’re very used to having to change course and figure out how to move ...

Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating ...